NXN

NEXSEN LTD FPO [NXN]
Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a farm diagnostic to detect mastitis early which helps farmers; biosecurity pathogen tests, a portable sensor for frontline detection of invasive pests and pathogens -built for customs officers, farmers, and quarantine zones. The company was incorporated in 2021 and is based in Sydney, Australia.
Healthcare · ASX Small Cap
$0.2850 +3.6%

Updated 22 Jul 2026 · Signals refresh every scan

Get alerts when NXN triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track NXN — Free

Active Signals

Bullish Signals

  • Stochastic just turned bullish from a low level — early reversal sign
  • Trading above both moving averages — the trend is your friend here
  • Beating the Small Ords index — relative strength of 1.33, so it's outpacing the pack
  • Adequate cash runway (8 quarters)
  • Very high P/S ratio (61.2x)
  • Small-cap ($20-100M)
  • CANSLIM S: Tight float (32%)
  • CANSLIM I: Institutional ownership (17%)
  • Sentiment is mixed — no strong consensus either way
  • The bigger volume days are the up days — volume-weighted momentum is positive (3.91%/day)
  • Altman Z-Score distress zone (1.76 < 1.81, low-confidence approx)
  • RBA hiking (-3pts)

Risk Signals

  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about NXN
"What's driving NXN today?" "How does NXN compare to peers?" "Key risks for NXN?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Global Healthcare CEO Joins Nexsen Advisory Board
NONE $1.5m non-dilutive ARC funding for manufacturing

Recent ASX Announcements

2026-06-29 Global Healthcare CEO Joins Nexsen Advisory Board
2026-06-24 $1.5m non-dilutive ARC funding for manufacturing PRICE SENSITIVE

Key Metrics

$57.1M
Market Cap
171K
Avg Volume
0.2x
Vol Ratio
$0.13 — $0.34
52-Week Range
N/A
Short Interest
N/A
Cash Runway
N/A
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual Earningsinsufficient_dataCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 32%
LLeader vs LaggardpassRS: 20
IInstitutional SponsorshippassInst: 17%
MMarket DirectionneutralNeutral

Sector: Healthcare

101 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
IDT +28.1%ADR +27.3%LDX +23.8%EYE +17.4%ECS -16.7%
Compare:NXN vs IDTNXN vs ADRNXN vs LDX
Scout Pro — Deeper Analysis for NXN
Try Pro free for 30 days
Share this analysis

Track NXN and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required